Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands.
Fine mapping of human cytotoxic T lymphocyte (CTL) responses against hepatitis C virus (HCV) is based on external loading of target cells with synthetic peptides which are either derived from prediction algorithms or from overlapping peptide libraries. These strategies do not address putative host a...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4cef024f9f8245f98e0db5123e0d99a3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4cef024f9f8245f98e0db5123e0d99a3 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4cef024f9f8245f98e0db5123e0d99a32021-11-18T07:31:09ZIdentification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands.1932-620310.1371/journal.pone.0029286https://doaj.org/article/4cef024f9f8245f98e0db5123e0d99a32012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235280/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Fine mapping of human cytotoxic T lymphocyte (CTL) responses against hepatitis C virus (HCV) is based on external loading of target cells with synthetic peptides which are either derived from prediction algorithms or from overlapping peptide libraries. These strategies do not address putative host and viral mechanisms which may alter processing as well as presentation of CTL epitopes. Therefore, the aim of this proof-of-concept study was to identify naturally processed HCV-derived major histocompatibility complex (MHC) class I ligands. To this end, continuous human cell lines were engineered to inducibly express HCV proteins and to constitutively express high levels of functional HLA-A2. These cell lines were recognized in an HLA-A2-restricted manner by HCV-specific CTLs. Ligands eluted from HLA-A2 molecules isolated from large-scale cultures of these cell lines were separated by high performance liquid chromatography and further analyzed by electrospray ionization quadrupole time of flight mass spectrometry (MS)/tandem MS. These analyses allowed the identification of two HLA-A2-restricted epitopes derived from HCV nonstructural proteins (NS) 3 and 5B (NS3₁₄₀₆₋₁₄₁₅ and NS5B₂₅₉₄₋₂₆₀₂). In conclusion, we describe a general strategy that may be useful to investigate HCV pathogenesis and may contribute to the development of preventive and therapeutic vaccines in the future.Benno WölkClaudia TrautweinBenjamin BücheleNadine KerstingHubert E BlumHans-Georg RammenseeAndreas CernyStefan StevanovicDarius MoradpourVolker BrassPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e29286 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Benno Wölk Claudia Trautwein Benjamin Büchele Nadine Kersting Hubert E Blum Hans-Georg Rammensee Andreas Cerny Stefan Stevanovic Darius Moradpour Volker Brass Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| description |
Fine mapping of human cytotoxic T lymphocyte (CTL) responses against hepatitis C virus (HCV) is based on external loading of target cells with synthetic peptides which are either derived from prediction algorithms or from overlapping peptide libraries. These strategies do not address putative host and viral mechanisms which may alter processing as well as presentation of CTL epitopes. Therefore, the aim of this proof-of-concept study was to identify naturally processed HCV-derived major histocompatibility complex (MHC) class I ligands. To this end, continuous human cell lines were engineered to inducibly express HCV proteins and to constitutively express high levels of functional HLA-A2. These cell lines were recognized in an HLA-A2-restricted manner by HCV-specific CTLs. Ligands eluted from HLA-A2 molecules isolated from large-scale cultures of these cell lines were separated by high performance liquid chromatography and further analyzed by electrospray ionization quadrupole time of flight mass spectrometry (MS)/tandem MS. These analyses allowed the identification of two HLA-A2-restricted epitopes derived from HCV nonstructural proteins (NS) 3 and 5B (NS3₁₄₀₆₋₁₄₁₅ and NS5B₂₅₉₄₋₂₆₀₂). In conclusion, we describe a general strategy that may be useful to investigate HCV pathogenesis and may contribute to the development of preventive and therapeutic vaccines in the future. |
| format |
article |
| author |
Benno Wölk Claudia Trautwein Benjamin Büchele Nadine Kersting Hubert E Blum Hans-Georg Rammensee Andreas Cerny Stefan Stevanovic Darius Moradpour Volker Brass |
| author_facet |
Benno Wölk Claudia Trautwein Benjamin Büchele Nadine Kersting Hubert E Blum Hans-Georg Rammensee Andreas Cerny Stefan Stevanovic Darius Moradpour Volker Brass |
| author_sort |
Benno Wölk |
| title |
Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| title_short |
Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| title_full |
Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| title_fullStr |
Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| title_full_unstemmed |
Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. |
| title_sort |
identification of naturally processed hepatitis c virus-derived major histocompatibility complex class i ligands. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/4cef024f9f8245f98e0db5123e0d99a3 |
| work_keys_str_mv |
AT bennowolk identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT claudiatrautwein identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT benjaminbuchele identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT nadinekersting identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT huberteblum identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT hansgeorgrammensee identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT andreascerny identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT stefanstevanovic identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT dariusmoradpour identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands AT volkerbrass identificationofnaturallyprocessedhepatitiscvirusderivedmajorhistocompatibilitycomplexclassiligands |
| _version_ |
1718423343857664000 |